Table 3.

MPs subtypes in mice

	%Ly6G	%CD14	%CD31	%CD41	%ECs	%Phall.
Control (19)	0.1 ± 0.1	44.3 ± 4.1	47.8 ± 5.7	29.1 ± 3.7	0.6 ± 0.1	2.3 ± 0.6
Control + pGSN (1)	1.0 ± 0.5	45.9 ± 5.1	36.1 ± 4.9	23.6 ± 4.4	0.8 ± 0.2	3.2 ± 0.7
Deco (1)	11.1 ± 1.9*	51.2 ± 3.5	36.8 ± 3.4	18.0 ± 3.3	2.3 ± 0.3*	29.4 ± 3.3*
Vehicle + Deco (1)	14.3 ± 2.5*	47.1 ± 3.3	49.4 ± 4.5	19.7 ± 3.4	1.7 ± 0.2*	24.5 ± 2.5*
pGSN + Deco (1)	3.9 ± 0.9*	50.6 ± 3.2	38.9 ± 3.6	21.1 ± 3.5	0.4 ± 0.1	4.5 ± 1.0
Deco + pGSN (1)	5.3 ± 0.8*	54.9 ± 6.8	40.2 ± 8.1	30.0 ± 5.7	0.5 ± 0.1	6.2 ± 2.0

Blood-borne MPs were quantified in male mice manipulated as described in the caption for Fig. 2 Flow cytometric measurements were made to quantify the number of all 0.3 to 1 µm diameter Annexin V-positive particles (data in Fig. 2) as well as the fraction of those expressing proteins specific to certain cells [Ly6G (mature neutrophils), CD14 (all leukocytes), CD31 (platelets and endothelium), CD41 (platelets), CD31+/ CD41-dim (endothelium, labeled ECs)] and also those that bound phalloidin (Phall). Data are expressed as means ± SE, n is shown for each sample; asterisk (*) and boldface indicates significantly different from control, P < 0.05, ANOVA. MP, microparticles; pGSN, plasma gelsolin.